CLOs on the Move

Blue Cross Blue Shield of Kansas

www.bcbsks.com

 
The largest health insurer in the state of Kansas. As a mutual insurance company, BCBSKS is owned by its policyholders. Its board of directors consists of Kansans from different areas of the state, 16 policyholders who bring to the table practical experience in business, medicine, hospital administration and education. Day-to-day operations are directed by a nine-person steering committee under the guidance of the company’s president/CEO. Customers and health care professionals have a voice in company activities through numerous advisory and liaison committees, as well as focus groups and surveys. BCBSKS is a financially secure, billion dollar company that contributes to ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.bcbsks.com
  • 1133 SW Topeka Boulevard
    Topeka, KS USA 66629
  • Phone: 785.291.7000

Executives

Name Title Contact Details
Clay Britton
Vice President of Legal and Compliance Services and General Counsel Profile
Dan Roehler
Chief Compliance Officer Profile
Matt All
President and Chief Executive officer Profile
Scott Raymond
Vice President of Legal Services and General Counsel Profile

Similar Companies

University HealthSystem Consortium

UHC, based in Oak Brook, Ill., and representing 0.7 of the academic medical centers in the United States, is an alliance of 84 academic medical centers and 80 associate members.

HFS Consultants

HFS Consultants is a Oakland, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medcan

Established over 25 years ago, Medcan is a global leader in assessing clients` overall well-being and inspiring them to live well. We partner with over 1,000 corporate accounts and 40,000 clients to set and achieve health and wellness goals.

Sherman Health Systems

Sherman Health Systems is a Elgin, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Aratana Terapeutics

Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of prescription medicines for pets in the United States and Europe. It develops AT-001, a prostaglandin E receptor 4 antagonist to treat the pain and inflammation associated with osteoarthritis in dogs, as well as for the management of pain in cats; AT-002, a potent and selective ghrelin agonist for the stimulation of appetite in cats and dogs; and AT-003, a bupivacaine liposome injectable suspension to manage post-operative pain in cats and dogs following surgery. The company was founded in 2010 and is headquartered in Kansas City, Kansas.